过剩2
杨梅素
非西汀
槲皮素
葡萄糖转运蛋白
果糖
化学
类黄酮
黄酮醇
生物化学
药理学
异鼠李素
生物
山奈酚
内分泌学
抗氧化剂
基因表达
胰岛素
基因
作者
Oran Kwon,Peter Eck,Shenglin Chen,Christopher Corpe,Je‐Hyuk Lee,Michael J. Kruhlak,Mark Levine
标识
DOI:10.1096/fj.06-6620com
摘要
We tested whether the dominant intestinal sugar transporter GLUT2 was inhibited by intestinal luminal compounds that are inefficiently absorbed and naturally present in foods. Because of their abundance in fruits and vegetables, flavonoids were selected as model compounds. Robust inhibition of glucose and fructose transport by GLUT2 expressed in Xenopus laevis oocytes was produced by the flavonols myricetin, fisetin, the widely consumed flavonoid quercetin, and its glucoside precursor isoquercitrin [corrected]. IC50s for quercetin, myricetin, and isoquercitirin [corrected]were approximately 200- to 1000-fold less than glucose or fructose concentrations, and noncompetitive inhibition was observed. The two other major intestinal sugar transporters, GLUT5 and SGLT1, were unaffected by flavonoids. Sugar transport by GLUT2 overexpressed in pituitary cells and naturally present in Caco-2E intestinal cells was similarly inhibited by quercetin. GLUT2 was detected on the apical side of Caco-2E cells, indicating that GLUT2 was in the correct orientation to be inhibited by luminal compounds. Quercetin itself was not transported by the three major intestinal glucose transporters. Because the flavonoid quercetin, a food component with an excellent pharmacology safety profile, might act as a potent luminal inhibitor of sugar absorption independent of its own transport, flavonols show promise as new pharmacologic agents in the obesity epidemic.
科研通智能强力驱动
Strongly Powered by AbleSci AI